Last update 01 Nov 2024
Beijing Boshi Antai Technology Development Co., Ltd.

Beijing Boshi Antai Technology Development Co., Ltd.

Private Company|
2007|
Beijing Shi, China
|
www.doctorante.com

Overview

Tags

Otorhinolaryngologic Diseases
Respiratory Diseases
Eye Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
α2A-AR(Alpha-2a adrenergic receptor)1

Related

2
Drugs associated with Beijing Boshi Antai Technology Development Co., Ltd.
Cefotiam hexetil hydrochloride
Target
α2A-AR
Mechanism
α2A-AR agonists
Active Org.
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd. [+1]
Originator Org.
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
Active Indication
Abscess [+16]
Inactive Indication
Acute Bronchitis [+9]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date01 Jan 1990
Cefotiam Hydrochloride
Target
PBPs
Mechanism
PBPs inhibitors [+1]
Active Org.
Teva Takeda Pharma Ltd.Teva Takeda Pharma Ltd.Startup [+1]
Originator Org.-
Active Indication
Acute Bronchitis [+17]
Inactive Indication
Urinary Tract Infections
Drug Highest PhaseApproved
First Approval Ctry. / Loc.-
First Approval Date01 Jan 1980
5
Clinical Trials associated with Beijing Boshi Antai Technology Development Co., Ltd.
CTR20150732 / SuspendedPhase 2
左乙拉西坦缓释片添加治疗癫痫部分性发作的有效性和安全性的多中心、随机、双盲、安慰剂平行对照临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of levetiracetam extended-release tablets as an add-on treatment for partial-onset epileptic seizures
CTR20150519 / RecruitingPhase 3
盐酸头孢替安酯片治疗轻、中度呼吸和泌尿系统急性细菌感染的 随机、双盲、阳性药平行对照、多中心临床试验
[Translation] A randomized, double-blind, positive-drug parallel-controlled, multicenter clinical trial of ceftriaxone hydrochloride tablets in the treatment of mild and moderate acute bacterial infections of the respiratory and urinary systems
CTR20150457 / Active, not recruiting
评价受试制剂阿戈美拉汀片25 mg和参比制剂维度新在中国男性健康受试者中的生物等效性研究
[Translation] A study to evaluate the bioequivalence of the test preparation agomelatine tablets 25 mg and the reference preparation Weiduxin in healthy Chinese male subjects
100 Clinical Results associated with Beijing Boshi Antai Technology Development Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Boshi Antai Technology Development Co., Ltd.
Login to view more data
100 Deals associated with Beijing Boshi Antai Technology Development Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Boshi Antai Technology Development Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Cefotiam hexetil hydrochloride
 ( α2A-AR )		Bacterial Infections
More
Phase 3
Cefotiam Hydrochloride
 ( PBPs )		Urinary Tract Infections
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free